Indivior extends deal with investor Scopia to keep boardmember Jerome Lande
17th Nov 2023 07:56
(Sharecast News) - Pharma group Indivior has extended its deal with shareholder Scopia Capital Management that will see the latter's representative Jerome Lande stay on the board until the end of next year.
Read moreLondon close: Stocks gain as investors await Powell speech
9th Nov 2023 15:02
(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.
Read moreIndivior swings to loss despite strong Sublocade performance
9th Nov 2023 08:39
(Sharecast News) - Indivior reported a solid third-quarter financial performance on Thursday, as Sublocade net revenue jumped 55% year-on-year to $167m, although a significant cash outflow saw it swing to a loss.
Read moreLondon close: Stocks mixed at start of busy week
23rd Oct 2023 19:21
(Sharecast News) - London's stock markets finished with a varied performance on Monday, driven by concerns over rising UK bond yields and global interest rate trends.
Read moreIndivior to pay $385m to settle multi-district Suboxone case
23rd Oct 2023 07:04
(Sharecast News) - Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.
Read moreIndivior settles part of US suboxone litigation
21st Aug 2023 07:23
(Sharecast News) - Addiction treatment specialist Indivior announced on Monday that its US subsidiary has entered into an agreement to settle the claims initiated by the end payor class in the ongoing multi-district suboxone antitrust litigation.
Read moreIndivior lifts guidance after strong first half
27th Jul 2023 10:04
(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.
Read moreIndivior reaches settlement in litigation with US states
5th Jun 2023 07:46
(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.
Read moreIndivior's opioid addiction sprat approved by FDA
23rd May 2023 07:48
(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.
Read moreIndivior lifts revenue guidance, cuts profit outlook after Opiant deal
27th Apr 2023 14:41
(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.
Read moreIndivior shares tumble as group sets aside $290m for US litigation
16th Feb 2023 07:54
(Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.
Read moreIndivior raises guidance for peak net revenue potential of Sublocade asset
7th Dec 2022 08:59
(Sharecast News) - Pharmaceuticals business Indivior upgraded guidance for the peak annual net revenue potential of its Sublocade asset on Wednesday ahead of its Capital Markets Day event in New York City.
Read moreIndivior to buy US overdose treatment firm Opiant for $145m
14th Nov 2022 07:05
(Sharecast News) - UK-based drug company Indivior said it would pay $145m for Opiant Pharmaceuticals which produces treatments to overcome opioid addiction.
Read moreIndivior ups FY guidance after solid third quarter
27th Oct 2022 10:17
(Sharecast News) - Opioid addiction treatment maker Indivior lifted its profit and revenue guidance for the year on Thursday following a "strong" third quarter.
Read moreIndivior profits fall on higher costs ahead of US listing
28th Jul 2022 09:31
(Sharecast News) - Pharmaceutical company Indivior reported a fall in interim profits due to rising costs.
Read more